

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | locomotory exploration behavior (GO:0035641) | 5.98185556 |
| 2 | lung epithelium development (GO:0060428) | 5.21447012 |
| 3 | neuron cell-cell adhesion (GO:0007158) | 5.03503093 |
| 4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.94453968 |
| 5 | vocalization behavior (GO:0071625) | 4.78697227 |
| 6 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.77832898 |
| 7 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.71311628 |
| 8 | exploration behavior (GO:0035640) | 4.60696506 |
| 9 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.58720442 |
| 10 | behavioral response to nicotine (GO:0035095) | 4.58618429 |
| 11 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.52413653 |
| 12 | synaptic vesicle exocytosis (GO:0016079) | 4.50645564 |
| 13 | protein localization to synapse (GO:0035418) | 4.35285611 |
| 14 | kidney morphogenesis (GO:0060993) | 4.33283804 |
| 15 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.29145237 |
| 16 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.24254341 |
| 17 | ATP synthesis coupled proton transport (GO:0015986) | 4.19180734 |
| 18 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.19180734 |
| 19 | neuron recognition (GO:0008038) | 4.14179012 |
| 20 | auditory behavior (GO:0031223) | 4.10877478 |
| 21 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.96107649 |
| 22 | response to pheromone (GO:0019236) | 3.92219493 |
| 23 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.90889980 |
| 24 | collecting duct development (GO:0072044) | 3.90642277 |
| 25 | layer formation in cerebral cortex (GO:0021819) | 3.89065509 |
| 26 | nucleobase catabolic process (GO:0046113) | 3.83322093 |
| 27 | glutamate secretion (GO:0014047) | 3.80225834 |
| 28 | synaptic vesicle maturation (GO:0016188) | 3.76978622 |
| 29 | cell migration in hindbrain (GO:0021535) | 3.71550194 |
| 30 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.65897897 |
| 31 | neuronal action potential propagation (GO:0019227) | 3.64019547 |
| 32 | neuron-neuron synaptic transmission (GO:0007270) | 3.63207585 |
| 33 | axon ensheathment in central nervous system (GO:0032291) | 3.61846605 |
| 34 | central nervous system myelination (GO:0022010) | 3.61846605 |
| 35 | glutamate receptor signaling pathway (GO:0007215) | 3.57773408 |
| 36 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.56685810 |
| 37 | axonal fasciculation (GO:0007413) | 3.56033706 |
| 38 | negative regulation of microtubule polymerization (GO:0031115) | 3.53763989 |
| 39 | dendritic spine morphogenesis (GO:0060997) | 3.53620270 |
| 40 | regulation of synapse maturation (GO:0090128) | 3.52944024 |
| 41 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.50610815 |
| 42 | neurotransmitter secretion (GO:0007269) | 3.46910077 |
| 43 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.45451957 |
| 44 | activation of protein kinase A activity (GO:0034199) | 3.45156716 |
| 45 | metanephric tubule development (GO:0072170) | 3.43907456 |
| 46 | metanephric nephron tubule development (GO:0072234) | 3.43907456 |
| 47 | synaptic transmission, glutamatergic (GO:0035249) | 3.41388577 |
| 48 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.40974813 |
| 49 | regulation of synaptic vesicle transport (GO:1902803) | 3.38731925 |
| 50 | transmission of nerve impulse (GO:0019226) | 3.32747668 |
| 51 | long-term memory (GO:0007616) | 3.31523680 |
| 52 | positive regulation of synapse assembly (GO:0051965) | 3.27025002 |
| 53 | postsynaptic membrane organization (GO:0001941) | 3.26411698 |
| 54 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.26399096 |
| 55 | dendrite morphogenesis (GO:0048813) | 3.21051797 |
| 56 | negative regulation of norepinephrine secretion (GO:0010700) | 3.20878339 |
| 57 | cell communication by electrical coupling (GO:0010644) | 3.16209013 |
| 58 | metanephric nephron epithelium development (GO:0072243) | 3.11700547 |
| 59 | establishment of mitochondrion localization (GO:0051654) | 3.11653726 |
| 60 | respiratory electron transport chain (GO:0022904) | 3.10320409 |
| 61 | proline transport (GO:0015824) | 3.07947343 |
| 62 | response to histamine (GO:0034776) | 3.06935667 |
| 63 | positive regulation of synapse maturation (GO:0090129) | 3.06771220 |
| 64 | startle response (GO:0001964) | 3.06135175 |
| 65 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.05431352 |
| 66 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.05326616 |
| 67 | somite development (GO:0061053) | 3.04226157 |
| 68 | electron transport chain (GO:0022900) | 3.02507509 |
| 69 | neuronal ion channel clustering (GO:0045161) | 3.01585936 |
| 70 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.01358057 |
| 71 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.01194617 |
| 72 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.01157294 |
| 73 | mechanosensory behavior (GO:0007638) | 3.00933165 |
| 74 | regulation of synapse structural plasticity (GO:0051823) | 2.98948264 |
| 75 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.96282198 |
| 76 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.95501156 |
| 77 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.95305629 |
| 78 | respiratory tube development (GO:0030323) | 2.94879125 |
| 79 | metanephric epithelium development (GO:0072207) | 2.94830568 |
| 80 | presynaptic membrane assembly (GO:0097105) | 2.93260232 |
| 81 | regulation of glucocorticoid secretion (GO:2000849) | 2.92030896 |
| 82 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.92013028 |
| 83 | regulation of norepinephrine secretion (GO:0014061) | 2.91226542 |
| 84 | dendritic spine organization (GO:0097061) | 2.90804617 |
| 85 | neuromuscular process controlling posture (GO:0050884) | 2.90152605 |
| 86 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.89666203 |
| 87 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.89666203 |
| 88 | membrane hyperpolarization (GO:0060081) | 2.89284105 |
| 89 | intra-S DNA damage checkpoint (GO:0031573) | 2.88024728 |
| 90 | synapse assembly (GO:0007416) | 2.85515583 |
| 91 | DNA methylation involved in gamete generation (GO:0043046) | 2.85501727 |
| 92 | regulation of respiratory gaseous exchange (GO:0043576) | 2.84963257 |
| 93 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.84920782 |
| 94 | positive regulation of action potential (GO:0045760) | 2.84003120 |
| 95 | regulation of vesicle fusion (GO:0031338) | 2.83815909 |
| 96 | nephron epithelium morphogenesis (GO:0072088) | 2.82360980 |
| 97 | nephron tubule morphogenesis (GO:0072078) | 2.82360980 |
| 98 | nephron tubule development (GO:0072080) | 2.82236870 |
| 99 | neurotransmitter transport (GO:0006836) | 2.81952620 |
| 100 | long-term synaptic potentiation (GO:0060291) | 2.81663273 |
| 101 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.80477904 |
| 102 | presynaptic membrane organization (GO:0097090) | 2.80254609 |
| 103 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.80209479 |
| 104 | negative regulation of catecholamine secretion (GO:0033604) | 2.78188211 |
| 105 | regulation of synapse assembly (GO:0051963) | 2.77378807 |
| 106 | detection of calcium ion (GO:0005513) | 2.76695476 |
| 107 | learning (GO:0007612) | 2.75919681 |
| 108 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.75631076 |
| 109 | phenylpropanoid metabolic process (GO:0009698) | 2.74980902 |
| 110 | cellular potassium ion homeostasis (GO:0030007) | 2.73425148 |
| 111 | cell communication involved in cardiac conduction (GO:0086065) | 2.73387555 |
| 112 | hippocampus development (GO:0021766) | 2.73079360 |
| 113 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.72716564 |
| 114 | anatomical structure regression (GO:0060033) | 2.71616252 |
| 115 | response to cocaine (GO:0042220) | 2.70483366 |
| 116 | gamma-aminobutyric acid transport (GO:0015812) | 2.69841695 |
| 117 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.69446492 |
| 118 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.69238985 |
| 119 | regulation of cell communication by electrical coupling (GO:0010649) | 2.69074135 |
| 120 | regulation of postsynaptic membrane potential (GO:0060078) | 2.68983960 |
| 121 | cellular response to ammonium ion (GO:0071242) | 2.68917593 |
| 122 | cochlea development (GO:0090102) | 2.68562014 |
| 123 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.68536024 |
| 124 | innervation (GO:0060384) | 2.68372567 |
| 125 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.68338285 |
| 126 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.67936840 |
| 127 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.67431173 |
| 128 | mitochondrion transport along microtubule (GO:0047497) | 2.67431173 |
| 129 | protein localization to cilium (GO:0061512) | 2.65215067 |
| 130 | lens fiber cell development (GO:0070307) | 2.64850536 |
| 131 | lung-associated mesenchyme development (GO:0060484) | 2.64297119 |
| 132 | membrane depolarization during action potential (GO:0086010) | 2.63837427 |
| 133 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.56977252 |
| 134 | response to auditory stimulus (GO:0010996) | 2.56349998 |
| 135 | neurotransmitter catabolic process (GO:0042135) | 2.54601164 |
| 136 | spinal cord development (GO:0021510) | 2.53981789 |
| 137 | phosphorelay signal transduction system (GO:0000160) | 2.53543310 |
| 138 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.49356158 |
| 139 | telencephalon development (GO:0021537) | 2.48607911 |
| 140 | positive regulation of gastrulation (GO:2000543) | 2.48578973 |
| 141 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:004316 | 2.46937978 |
| 142 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 2.45950476 |
| 143 | action potential (GO:0001508) | 2.45498122 |
| 144 | neuromuscular synaptic transmission (GO:0007274) | 2.45098444 |
| 145 | potassium ion import (GO:0010107) | 2.44370769 |
| 146 | renal tubule development (GO:0061326) | 2.44171175 |
| 147 | nonmotile primary cilium assembly (GO:0035058) | 2.43239145 |
| 148 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.42990436 |
| 149 | cerebellar granule cell differentiation (GO:0021707) | 2.42411955 |
| 150 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.40617730 |
| 151 | body morphogenesis (GO:0010171) | 2.39774033 |
| 152 | membrane repolarization during action potential (GO:0086011) | 2.39597198 |
| 153 | synaptic transmission, cholinergic (GO:0007271) | 2.38266554 |
| 154 | phenol-containing compound catabolic process (GO:0019336) | 2.37093817 |
| 155 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.36699422 |
| 156 | neuronal action potential (GO:0019228) | 2.36080539 |
| 157 | regulation of neurotransmitter levels (GO:0001505) | 2.33639146 |
| 158 | substrate-independent telencephalic tangential migration (GO:0021826) | 2.33531604 |
| 159 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 2.33531604 |
| 160 | cardiac conduction (GO:0061337) | 2.33270838 |
| 161 | adult walking behavior (GO:0007628) | 2.31316208 |
| 162 | nephron epithelium development (GO:0072009) | 2.31177171 |
| 163 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.30968328 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.25724771 |
| 2 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 4.45829282 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.65034313 |
| 4 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.26354795 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.18775944 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.16774480 |
| 7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.13889419 |
| 8 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.94509229 |
| 9 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.79764426 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.73010574 |
| 11 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.72760737 |
| 12 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.72760737 |
| 13 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.72358283 |
| 14 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.70431946 |
| 15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.64474543 |
| 16 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.61336650 |
| 17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.60800798 |
| 18 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.49413566 |
| 19 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.46550066 |
| 20 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.44137489 |
| 21 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.41972181 |
| 22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.41633814 |
| 23 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.38281634 |
| 24 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.18891643 |
| 25 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.18743536 |
| 26 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.16752809 |
| 27 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.08171550 |
| 28 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.02522170 |
| 29 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.00649004 |
| 30 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.95794446 |
| 31 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.93006318 |
| 32 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.82256110 |
| 33 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.74061773 |
| 34 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.73922276 |
| 35 | VDR_22108803_ChIP-Seq_LS180_Human | 1.71655261 |
| 36 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.69514526 |
| 37 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.62160172 |
| 38 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.61306981 |
| 39 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.61260509 |
| 40 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.58582914 |
| 41 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.55825822 |
| 42 | P300_19829295_ChIP-Seq_ESCs_Human | 1.52942132 |
| 43 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.52702661 |
| 44 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.52636307 |
| 45 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.48675927 |
| 46 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.47808114 |
| 47 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.46844721 |
| 48 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.46227092 |
| 49 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.42994187 |
| 50 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.41699195 |
| 51 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.37567827 |
| 52 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.36992537 |
| 53 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.34426122 |
| 54 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.34418618 |
| 55 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.33812962 |
| 56 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.30154062 |
| 57 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.30018094 |
| 58 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.29859793 |
| 59 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.28601168 |
| 60 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.26170857 |
| 61 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.24129285 |
| 62 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.22982670 |
| 63 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.22518268 |
| 64 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.22362713 |
| 65 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.21867931 |
| 66 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.21653345 |
| 67 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.17679192 |
| 68 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.17633242 |
| 69 | AR_25329375_ChIP-Seq_VCAP_Human | 1.17219930 |
| 70 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.16354071 |
| 71 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.11850591 |
| 72 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.10458412 |
| 73 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10458412 |
| 74 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.09489570 |
| 75 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.08271657 |
| 76 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.06967434 |
| 77 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06666076 |
| 78 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.06232301 |
| 79 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.04283938 |
| 80 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.03976074 |
| 81 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.03758948 |
| 82 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.03414268 |
| 83 | KDM2B_26808549_Chip-Seq_K562_Human | 1.03350462 |
| 84 | P68_20966046_ChIP-Seq_HELA_Human | 1.03326641 |
| 85 | FUS_26573619_Chip-Seq_HEK293_Human | 1.02671799 |
| 86 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.01988341 |
| 87 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.01648703 |
| 88 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.00925414 |
| 89 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.99125293 |
| 90 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.98597733 |
| 91 | JUN_21703547_ChIP-Seq_K562_Human | 0.97616026 |
| 92 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.97370080 |
| 93 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.96944747 |
| 94 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.96767725 |
| 95 | AR_19668381_ChIP-Seq_PC3_Human | 0.96326127 |
| 96 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.96184965 |
| 97 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.95875456 |
| 98 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95500889 |
| 99 | STAT3_23295773_ChIP-Seq_U87_Human | 0.94905467 |
| 100 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.94330414 |
| 101 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.93345875 |
| 102 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.93239979 |
| 103 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.91975515 |
| 104 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.91738332 |
| 105 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.90933096 |
| 106 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.90050745 |
| 107 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.89896440 |
| 108 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.89841253 |
| 109 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.89772801 |
| 110 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.89772801 |
| 111 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.89366472 |
| 112 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.88478426 |
| 113 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 0.88025053 |
| 114 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.87773916 |
| 115 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.87473721 |
| 116 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.87435692 |
| 117 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.87395222 |
| 118 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.87001143 |
| 119 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.86024706 |
| 120 | TCF4_23295773_ChIP-Seq_U87_Human | 0.85973800 |
| 121 | ERA_21632823_ChIP-Seq_H3396_Human | 0.85911923 |
| 122 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.82183571 |
| 123 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.81766853 |
| 124 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.81210637 |
| 125 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.80339006 |
| 126 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.80213318 |
| 127 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.80167900 |
| 128 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.80156832 |
| 129 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.80051136 |
| 130 | SOX3_22085726_ChIP-Seq_NPCs_Mouse | 0.78641607 |
| 131 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.77294846 |
| 132 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.76948205 |
| 133 | SA1_27219007_Chip-Seq_Bcells_Human | 0.76468229 |
| 134 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.76161203 |
| 135 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.75237774 |
| 136 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.74940457 |
| 137 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 0.74805586 |
| 138 | NCOR_22424771_ChIP-Seq_293T_Human | 0.74356984 |
| 139 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.74285167 |
| 140 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.73403707 |
| 141 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.72729788 |
| 142 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.72488744 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.47635837 |
| 2 | MP0003880_abnormal_central_pattern | 4.36712769 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.47077090 |
| 4 | MP0004270_analgesia | 3.14569574 |
| 5 | MP0005423_abnormal_somatic_nervous | 3.02936326 |
| 6 | MP0006276_abnormal_autonomic_nervous | 3.01462470 |
| 7 | MP0001968_abnormal_touch/_nociception | 3.01101301 |
| 8 | MP0002735_abnormal_chemical_nociception | 2.94902846 |
| 9 | MP0002063_abnormal_learning/memory/cond | 2.83719904 |
| 10 | MP0009745_abnormal_behavioral_response | 2.75441708 |
| 11 | MP0006292_abnormal_olfactory_placode | 2.64991399 |
| 12 | MP0003122_maternal_imprinting | 2.62365902 |
| 13 | MP0002064_seizures | 2.55815076 |
| 14 | MP0009046_muscle_twitch | 2.52591859 |
| 15 | MP0002572_abnormal_emotion/affect_behav | 2.50291311 |
| 16 | MP0002734_abnormal_mechanical_nocicepti | 2.45071158 |
| 17 | MP0001440_abnormal_grooming_behavior | 2.35654296 |
| 18 | MP0002736_abnormal_nociception_after | 2.33221955 |
| 19 | MP0000778_abnormal_nervous_system | 2.32150911 |
| 20 | MP0002272_abnormal_nervous_system | 2.29194478 |
| 21 | MP0000751_myopathy | 2.19792900 |
| 22 | MP0002184_abnormal_innervation | 2.18812863 |
| 23 | MP0010030_abnormal_orbit_morphology | 2.18682725 |
| 24 | MP0001486_abnormal_startle_reflex | 2.18093461 |
| 25 | MP0002837_dystrophic_cardiac_calcinosis | 2.17884653 |
| 26 | MP0001529_abnormal_vocalization | 2.08300999 |
| 27 | MP0002733_abnormal_thermal_nociception | 2.07406681 |
| 28 | MP0001984_abnormal_olfaction | 2.04616148 |
| 29 | MP0000566_synostosis | 2.03154644 |
| 30 | MP0002067_abnormal_sensory_capabilities | 1.89416882 |
| 31 | MP0005645_abnormal_hypothalamus_physiol | 1.88532476 |
| 32 | MP0001970_abnormal_pain_threshold | 1.83543659 |
| 33 | MP0005386_behavior/neurological_phenoty | 1.82004938 |
| 34 | MP0004924_abnormal_behavior | 1.82004938 |
| 35 | MP0003136_yellow_coat_color | 1.77809472 |
| 36 | MP0004858_abnormal_nervous_system | 1.74965543 |
| 37 | MP0003283_abnormal_digestive_organ | 1.74556168 |
| 38 | MP0009780_abnormal_chondrocyte_physiolo | 1.74072970 |
| 39 | MP0002557_abnormal_social/conspecific_i | 1.70878400 |
| 40 | MP0003329_amyloid_beta_deposits | 1.70447889 |
| 41 | MP0001501_abnormal_sleep_pattern | 1.68873094 |
| 42 | MP0004147_increased_porphyrin_level | 1.56289048 |
| 43 | MP0008877_abnormal_DNA_methylation | 1.53935587 |
| 44 | MP0002822_catalepsy | 1.53391471 |
| 45 | MP0004811_abnormal_neuron_physiology | 1.52674111 |
| 46 | MP0002909_abnormal_adrenal_gland | 1.49118455 |
| 47 | MP0004142_abnormal_muscle_tone | 1.45083940 |
| 48 | MP0002938_white_spotting | 1.43057837 |
| 49 | MP0004133_heterotaxia | 1.42152748 |
| 50 | MP0002882_abnormal_neuron_morphology | 1.41011374 |
| 51 | MP0000049_abnormal_middle_ear | 1.40461092 |
| 52 | MP0008995_early_reproductive_senescence | 1.39127662 |
| 53 | MP0000678_abnormal_parathyroid_gland | 1.38411511 |
| 54 | MP0000955_abnormal_spinal_cord | 1.38385957 |
| 55 | MP0002163_abnormal_gland_morphology | 1.38168510 |
| 56 | MP0003646_muscle_fatigue | 1.34153457 |
| 57 | MP0005499_abnormal_olfactory_system | 1.32626709 |
| 58 | MP0005394_taste/olfaction_phenotype | 1.32626709 |
| 59 | MP0008875_abnormal_xenobiotic_pharmacok | 1.29545168 |
| 60 | MP0002066_abnormal_motor_capabilities/c | 1.28960910 |
| 61 | MP0004233_abnormal_muscle_weight | 1.27119044 |
| 62 | MP0004215_abnormal_myocardial_fiber | 1.26519250 |
| 63 | MP0003879_abnormal_hair_cell | 1.26189098 |
| 64 | MP0003183_abnormal_peptide_metabolism | 1.25765318 |
| 65 | MP0001502_abnormal_circadian_rhythm | 1.24518992 |
| 66 | MP0005646_abnormal_pituitary_gland | 1.24391117 |
| 67 | MP0003195_calcinosis | 1.22874998 |
| 68 | MP0003137_abnormal_impulse_conducting | 1.22613839 |
| 69 | MP0004085_abnormal_heartbeat | 1.21668044 |
| 70 | MP0002653_abnormal_ependyma_morphology | 1.19395569 |
| 71 | MP0003938_abnormal_ear_development | 1.18692839 |
| 72 | MP0008569_lethality_at_weaning | 1.18563652 |
| 73 | MP0004484_altered_response_of | 1.18225985 |
| 74 | MP0003121_genomic_imprinting | 1.17922767 |
| 75 | MP0004742_abnormal_vestibular_system | 1.13436971 |
| 76 | MP0004885_abnormal_endolymph | 1.10195176 |
| 77 | MP0002152_abnormal_brain_morphology | 1.08972402 |
| 78 | MP0001485_abnormal_pinna_reflex | 1.08914811 |
| 79 | MP0001346_abnormal_lacrimal_gland | 1.08518451 |
| 80 | MP0004019_abnormal_vitamin_homeostasis | 1.07570349 |
| 81 | MP0001188_hyperpigmentation | 1.02873706 |
| 82 | MP0008789_abnormal_olfactory_epithelium | 1.02082400 |
| 83 | MP0008961_abnormal_basal_metabolism | 0.99442836 |
| 84 | MP0000631_abnormal_neuroendocrine_gland | 0.97605789 |
| 85 | MP0002752_abnormal_somatic_nervous | 0.97546813 |
| 86 | MP0003890_abnormal_embryonic-extraembry | 0.96143146 |
| 87 | MP0002249_abnormal_larynx_morphology | 0.92029455 |
| 88 | MP0003123_paternal_imprinting | 0.91602398 |
| 89 | MP0005083_abnormal_biliary_tract | 0.91482083 |
| 90 | MP0005365_abnormal_bile_salt | 0.91452625 |
| 91 | MP0005670_abnormal_white_adipose | 0.91385787 |
| 92 | MP0001905_abnormal_dopamine_level | 0.91253606 |
| 93 | MP0005551_abnormal_eye_electrophysiolog | 0.90302237 |
| 94 | MP0005195_abnormal_posterior_eye | 0.89897658 |
| 95 | MP0009379_abnormal_foot_pigmentation | 0.86700275 |
| 96 | MP0010329_abnormal_lipoprotein_level | 0.85720864 |
| 97 | MP0004036_abnormal_muscle_relaxation | 0.84589883 |
| 98 | MP0002876_abnormal_thyroid_physiology | 0.83284080 |
| 99 | MP0009384_cardiac_valve_regurgitation | 0.83199848 |
| 100 | MP0002229_neurodegeneration | 0.82820678 |
| 101 | MP0008775_abnormal_heart_ventricle | 0.81982680 |
| 102 | MP0001963_abnormal_hearing_physiology | 0.81200745 |
| 103 | MP0001944_abnormal_pancreas_morphology | 0.80918647 |
| 104 | MP0002069_abnormal_eating/drinking_beha | 0.80351919 |
| 105 | MP0004084_abnormal_cardiac_muscle | 0.79764337 |
| 106 | MP0003119_abnormal_digestive_system | 0.79445409 |
| 107 | MP0001299_abnormal_eye_distance/ | 0.78555040 |
| 108 | MP0003878_abnormal_ear_physiology | 0.76807895 |
| 109 | MP0005377_hearing/vestibular/ear_phenot | 0.76807895 |
| 110 | MP0005379_endocrine/exocrine_gland_phen | 0.75904928 |
| 111 | MP0000013_abnormal_adipose_tissue | 0.74645403 |
| 112 | MP0002972_abnormal_cardiac_muscle | 0.74613588 |
| 113 | MP0003787_abnormal_imprinting | 0.74494457 |
| 114 | MP0000604_amyloidosis | 0.74459488 |
| 115 | MP0002751_abnormal_autonomic_nervous | 0.73584934 |
| 116 | MP0006035_abnormal_mitochondrial_morpho | 0.73360348 |
| 117 | MP0000026_abnormal_inner_ear | 0.73341218 |
| 118 | MP0004145_abnormal_muscle_electrophysio | 0.72393246 |
| 119 | MP0002102_abnormal_ear_morphology | 0.72273855 |
| 120 | MP0003861_abnormal_nervous_system | 0.72155528 |
| 121 | MP0001727_abnormal_embryo_implantation | 0.71016282 |
| 122 | MP0005620_abnormal_muscle_contractility | 0.70819601 |
| 123 | MP0003633_abnormal_nervous_system | 0.70663867 |
| 124 | MP0001986_abnormal_taste_sensitivity | 0.69474927 |
| 125 | MP0002638_abnormal_pupillary_reflex | 0.68758294 |
| 126 | MP0008872_abnormal_physiological_respon | 0.67639920 |
| 127 | MP0003634_abnormal_glial_cell | 0.67631538 |
| 128 | MP0005623_abnormal_meninges_morphology | 0.66558843 |
| 129 | MP0004130_abnormal_muscle_cell | 0.66532354 |
| 130 | MP0003631_nervous_system_phenotype | 0.62518315 |
| 131 | MP0002106_abnormal_muscle_physiology | 0.61645682 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.96753049 |
| 2 | Myokymia (HP:0002411) | 5.22656136 |
| 3 | Focal seizures (HP:0007359) | 4.67183811 |
| 4 | Atonic seizures (HP:0010819) | 4.28716734 |
| 5 | Epileptic encephalopathy (HP:0200134) | 4.20664801 |
| 6 | Nephronophthisis (HP:0000090) | 4.08186935 |
| 7 | Visual hallucinations (HP:0002367) | 4.06130126 |
| 8 | Acute necrotizing encephalopathy (HP:0006965) | 3.94982800 |
| 9 | Polyphagia (HP:0002591) | 3.93494439 |
| 10 | Absence seizures (HP:0002121) | 3.75240775 |
| 11 | True hermaphroditism (HP:0010459) | 3.71927474 |
| 12 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.71132473 |
| 13 | Pancreatic fibrosis (HP:0100732) | 3.70641248 |
| 14 | Polydipsia (HP:0001959) | 3.68721659 |
| 15 | Abnormal drinking behavior (HP:0030082) | 3.68721659 |
| 16 | Febrile seizures (HP:0002373) | 3.61519292 |
| 17 | Severe visual impairment (HP:0001141) | 3.58846604 |
| 18 | Abnormality of the aortic arch (HP:0012303) | 3.57206487 |
| 19 | Failure to thrive in infancy (HP:0001531) | 3.48679472 |
| 20 | Progressive macrocephaly (HP:0004481) | 3.44662722 |
| 21 | Pheochromocytoma (HP:0002666) | 3.44157221 |
| 22 | Dialeptic seizures (HP:0011146) | 3.31353511 |
| 23 | Neuroendocrine neoplasm (HP:0100634) | 3.22644107 |
| 24 | Abnormality of the renal medulla (HP:0100957) | 3.22031173 |
| 25 | Progressive cerebellar ataxia (HP:0002073) | 3.13319798 |
| 26 | Progressive inability to walk (HP:0002505) | 3.06483241 |
| 27 | Type II lissencephaly (HP:0007260) | 3.04832833 |
| 28 | Generalized tonic-clonic seizures (HP:0002069) | 3.04085759 |
| 29 | Tubular atrophy (HP:0000092) | 2.95210345 |
| 30 | Limb dystonia (HP:0002451) | 2.95067498 |
| 31 | Polyuria (HP:0000103) | 2.95029363 |
| 32 | Abnormal eating behavior (HP:0100738) | 2.91962521 |
| 33 | Broad-based gait (HP:0002136) | 2.91741650 |
| 34 | Amblyopia (HP:0000646) | 2.89139614 |
| 35 | Acute encephalopathy (HP:0006846) | 2.88280986 |
| 36 | Pancreatic cysts (HP:0001737) | 2.88238018 |
| 37 | Abnormal urine output (HP:0012590) | 2.83775915 |
| 38 | Cystic liver disease (HP:0006706) | 2.78104687 |
| 39 | Mitochondrial inheritance (HP:0001427) | 2.77510524 |
| 40 | Mutism (HP:0002300) | 2.77379993 |
| 41 | Abnormality of the labia minora (HP:0012880) | 2.76007851 |
| 42 | Abnormality of renal excretion (HP:0011036) | 2.71325444 |
| 43 | Abnormality of glycolysis (HP:0004366) | 2.70820454 |
| 44 | Increased serum pyruvate (HP:0003542) | 2.70820454 |
| 45 | Sclerocornea (HP:0000647) | 2.67462527 |
| 46 | Sudden death (HP:0001699) | 2.66662503 |
| 47 | Truncus arteriosus (HP:0001660) | 2.64459992 |
| 48 | Abnormality of the renal cortex (HP:0011035) | 2.63670076 |
| 49 | Hyperventilation (HP:0002883) | 2.61173389 |
| 50 | Molar tooth sign on MRI (HP:0002419) | 2.56684332 |
| 51 | Abnormality of midbrain morphology (HP:0002418) | 2.56684332 |
| 52 | Decreased circulating renin level (HP:0003351) | 2.56626001 |
| 53 | Supranuclear gaze palsy (HP:0000605) | 2.47927278 |
| 54 | Abnormality of the corticospinal tract (HP:0002492) | 2.46072346 |
| 55 | Termporal pattern (HP:0011008) | 2.44299255 |
| 56 | Insidious onset (HP:0003587) | 2.44299255 |
| 57 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.42902976 |
| 58 | Hypoplasia of the brainstem (HP:0002365) | 2.42902976 |
| 59 | Excessive salivation (HP:0003781) | 2.40729251 |
| 60 | Drooling (HP:0002307) | 2.40729251 |
| 61 | Oligomenorrhea (HP:0000876) | 2.40435030 |
| 62 | Urinary urgency (HP:0000012) | 2.40316400 |
| 63 | Ankle clonus (HP:0011448) | 2.39684471 |
| 64 | Congenital hepatic fibrosis (HP:0002612) | 2.38963334 |
| 65 | Cerebellar dysplasia (HP:0007033) | 2.38909767 |
| 66 | Epileptiform EEG discharges (HP:0011182) | 2.38632019 |
| 67 | EEG with generalized epileptiform discharges (HP:0011198) | 2.38099727 |
| 68 | Tubulointerstitial fibrosis (HP:0005576) | 2.34395771 |
| 69 | Specific learning disability (HP:0001328) | 2.33662526 |
| 70 | Poor suck (HP:0002033) | 2.31341448 |
| 71 | Optic disc pallor (HP:0000543) | 2.31084647 |
| 72 | Medial flaring of the eyebrow (HP:0010747) | 2.30611272 |
| 73 | Increased CSF lactate (HP:0002490) | 2.28668276 |
| 74 | Truncal ataxia (HP:0002078) | 2.28352085 |
| 75 | Hypsarrhythmia (HP:0002521) | 2.26413599 |
| 76 | Growth hormone deficiency (HP:0000824) | 2.26187798 |
| 77 | Abnormal hair whorl (HP:0010721) | 2.24139994 |
| 78 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.21911313 |
| 79 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.21377459 |
| 80 | Stage 5 chronic kidney disease (HP:0003774) | 2.21148689 |
| 81 | Neurofibrillary tangles (HP:0002185) | 2.20949430 |
| 82 | Cerebral inclusion bodies (HP:0100314) | 2.20233377 |
| 83 | Anencephaly (HP:0002323) | 2.20226802 |
| 84 | Anxiety (HP:0000739) | 2.19849753 |
| 85 | Male pseudohermaphroditism (HP:0000037) | 2.17027243 |
| 86 | Gait imbalance (HP:0002141) | 2.14183884 |
| 87 | Poor eye contact (HP:0000817) | 2.13085424 |
| 88 | Occipital encephalocele (HP:0002085) | 2.11325875 |
| 89 | Fetal akinesia sequence (HP:0001989) | 2.11197933 |
| 90 | Poor coordination (HP:0002370) | 2.10881916 |
| 91 | Syncope (HP:0001279) | 2.10190961 |
| 92 | Severe muscular hypotonia (HP:0006829) | 2.08758570 |
| 93 | Esotropia (HP:0000565) | 2.08594475 |
| 94 | Action tremor (HP:0002345) | 2.08431775 |
| 95 | Hypoventilation (HP:0002791) | 2.07889502 |
| 96 | Sleep apnea (HP:0010535) | 2.05365142 |
| 97 | Leukodystrophy (HP:0002415) | 2.04912981 |
| 98 | Abnormal social behavior (HP:0012433) | 2.04395591 |
| 99 | Impaired social interactions (HP:0000735) | 2.04395591 |
| 100 | Depression (HP:0000716) | 2.04027719 |
| 101 | Agitation (HP:0000713) | 2.04019925 |
| 102 | Rib fusion (HP:0000902) | 2.02292828 |
| 103 | Calf muscle hypertrophy (HP:0008981) | 2.01872673 |
| 104 | Confusion (HP:0001289) | 2.01644060 |
| 105 | Status epilepticus (HP:0002133) | 2.01320809 |
| 106 | Chronic hepatic failure (HP:0100626) | 2.00055091 |
| 107 | Inability to walk (HP:0002540) | 1.99667719 |
| 108 | Generalized hypotonia (HP:0001290) | 1.99538176 |
| 109 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.99337843 |
| 110 | Shawl scrotum (HP:0000049) | 1.97917747 |
| 111 | Cerebral edema (HP:0002181) | 1.96955314 |
| 112 | Hyperthyroidism (HP:0000836) | 1.96357105 |
| 113 | Amyotrophic lateral sclerosis (HP:0007354) | 1.95974116 |
| 114 | Hemiparesis (HP:0001269) | 1.95718064 |
| 115 | Concave nail (HP:0001598) | 1.95492319 |
| 116 | Tachypnea (HP:0002789) | 1.95310826 |
| 117 | Spastic gait (HP:0002064) | 1.95153344 |
| 118 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.95099292 |
| 119 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.93475454 |
| 120 | Anophthalmia (HP:0000528) | 1.93173557 |
| 121 | Torticollis (HP:0000473) | 1.92449318 |
| 122 | Postaxial foot polydactyly (HP:0001830) | 1.91187117 |
| 123 | Abnormality of pain sensation (HP:0010832) | 1.91090687 |
| 124 | Impaired pain sensation (HP:0007328) | 1.91090687 |
| 125 | Broad alveolar ridges (HP:0000187) | 1.90083016 |
| 126 | Lissencephaly (HP:0001339) | 1.89826303 |
| 127 | Maternal diabetes (HP:0009800) | 1.88507526 |
| 128 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.87206885 |
| 129 | Dysdiadochokinesis (HP:0002075) | 1.86141849 |
| 130 | Congenital primary aphakia (HP:0007707) | 1.85904544 |
| 131 | Progressive external ophthalmoplegia (HP:0000590) | 1.84132018 |
| 132 | Prolonged QT interval (HP:0001657) | 1.83869840 |
| 133 | Severe Myopia (HP:0011003) | 1.83499389 |
| 134 | Primary atrial arrhythmia (HP:0001692) | 1.83065290 |
| 135 | Abnormality of the calf musculature (HP:0001430) | 1.82072434 |
| 136 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.81975797 |
| 137 | Abnormal EKG (HP:0003115) | 1.81334801 |
| 138 | Narrow nasal bridge (HP:0000446) | 1.81308933 |
| 139 | Hyperphosphatemia (HP:0002905) | 1.81124859 |
| 140 | Ventricular fibrillation (HP:0001663) | 1.80127479 |
| 141 | Oligodactyly (hands) (HP:0001180) | 1.80054753 |
| 142 | Nephrogenic diabetes insipidus (HP:0009806) | 1.78820374 |
| 143 | Impulsivity (HP:0100710) | 1.78670901 |
| 144 | Akinesia (HP:0002304) | 1.78306403 |
| 145 | X-linked dominant inheritance (HP:0001423) | 1.78028474 |
| 146 | Abnormality of the vitreous humor (HP:0004327) | 1.77930308 |
| 147 | Genetic anticipation (HP:0003743) | 1.77738063 |
| 148 | Hyperglycinuria (HP:0003108) | 1.77169559 |
| 149 | Myotonia (HP:0002486) | 1.76788646 |
| 150 | Exercise-induced myalgia (HP:0003738) | 1.76599258 |
| 151 | Sporadic (HP:0003745) | 1.76329561 |
| 152 | Supraventricular tachycardia (HP:0004755) | 1.76156167 |
| 153 | Decreased central vision (HP:0007663) | 1.74787009 |
| 154 | Spastic tetraplegia (HP:0002510) | 1.72137093 |
| 155 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.72127163 |
| 156 | Furrowed tongue (HP:0000221) | 1.71429875 |
| 157 | Retinal dysplasia (HP:0007973) | 1.68540952 |
| 158 | Enlarged penis (HP:0000040) | 1.68041571 |
| 159 | Abnormality of the nasal septum (HP:0000419) | 1.66931921 |
| 160 | Left ventricular hypertrophy (HP:0001712) | 1.66100059 |
| 161 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.66069524 |
| 162 | Tubulointerstitial abnormality (HP:0001969) | 1.63812255 |
| 163 | Optic nerve hypoplasia (HP:0000609) | 1.61208478 |
| 164 | Potter facies (HP:0002009) | 1.60549027 |
| 165 | Facial shape deformation (HP:0011334) | 1.60549027 |
| 166 | Abnormality of renin-angiotensin system (HP:0000847) | 1.60439540 |
| 167 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.59996742 |
| 168 | Absent epiphyses (HP:0010577) | 1.59996742 |
| 169 | Hypercalciuria (HP:0002150) | 1.55763876 |
| 170 | Optic nerve coloboma (HP:0000588) | 1.55175918 |
| 171 | Septo-optic dysplasia (HP:0100842) | 1.54329791 |
| 172 | Polycystic kidney dysplasia (HP:0000113) | 1.53795990 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MARK1 | 5.33752684 |
| 2 | NTRK3 | 3.59901030 |
| 3 | WNK4 | 3.19364941 |
| 4 | MAP3K12 | 2.96667513 |
| 5 | MAP3K9 | 2.92806490 |
| 6 | MINK1 | 2.85401157 |
| 7 | PINK1 | 2.75010491 |
| 8 | MAP3K4 | 2.72302329 |
| 9 | NTRK2 | 2.43169616 |
| 10 | PASK | 2.42738639 |
| 11 | CASK | 2.41796016 |
| 12 | MAP2K7 | 2.31086085 |
| 13 | MAPK15 | 2.29517514 |
| 14 | PHKG1 | 2.28063094 |
| 15 | PHKG2 | 2.28063094 |
| 16 | MAPK13 | 2.20992806 |
| 17 | CAMKK1 | 2.11038019 |
| 18 | KSR1 | 1.95852885 |
| 19 | MAP2K4 | 1.91433300 |
| 20 | EPHA4 | 1.79050764 |
| 21 | NME1 | 1.73053990 |
| 22 | ZAK | 1.69921781 |
| 23 | PAK6 | 1.69199183 |
| 24 | FRK | 1.65903027 |
| 25 | PLK2 | 1.61783965 |
| 26 | SIK3 | 1.55411025 |
| 27 | UHMK1 | 1.53861908 |
| 28 | DAPK2 | 1.50567980 |
| 29 | SIK2 | 1.39458651 |
| 30 | LATS2 | 1.38879365 |
| 31 | PNCK | 1.38443814 |
| 32 | GRK5 | 1.28817904 |
| 33 | CDK5 | 1.24244593 |
| 34 | RIPK1 | 1.22949408 |
| 35 | DYRK3 | 1.22345130 |
| 36 | NTRK1 | 1.19149178 |
| 37 | DYRK2 | 1.18030685 |
| 38 | STK39 | 1.17752133 |
| 39 | GRK7 | 1.17153468 |
| 40 | EPHB2 | 1.16437513 |
| 41 | TIE1 | 1.15759019 |
| 42 | GRK1 | 1.13322817 |
| 43 | DAPK1 | 1.11443097 |
| 44 | BCR | 1.10144820 |
| 45 | PAK3 | 1.09777002 |
| 46 | CAMK2A | 1.06271194 |
| 47 | LIMK1 | 1.05685960 |
| 48 | PKN2 | 1.04463128 |
| 49 | PRKCG | 1.03172495 |
| 50 | CAMK2D | 1.01076342 |
| 51 | BRSK1 | 1.00710765 |
| 52 | ARAF | 0.99983448 |
| 53 | KSR2 | 0.99661640 |
| 54 | TLK1 | 0.96862346 |
| 55 | PRKD3 | 0.92875197 |
| 56 | PDK3 | 0.92197615 |
| 57 | PDK4 | 0.92197615 |
| 58 | ERBB3 | 0.90845632 |
| 59 | WNK1 | 0.89397587 |
| 60 | CDK19 | 0.89318742 |
| 61 | TAOK1 | 0.88951130 |
| 62 | MAPK12 | 0.88809416 |
| 63 | CDK14 | 0.88648216 |
| 64 | MARK2 | 0.86663263 |
| 65 | MAPKAPK5 | 0.86661078 |
| 66 | ERBB2 | 0.86603727 |
| 67 | FES | 0.85991132 |
| 68 | CAMK2B | 0.84763263 |
| 69 | TYRO3 | 0.84705117 |
| 70 | CDK18 | 0.82430552 |
| 71 | DYRK1B | 0.79529870 |
| 72 | DYRK1A | 0.78753194 |
| 73 | SIK1 | 0.77681692 |
| 74 | CSNK1G2 | 0.76456910 |
| 75 | PRKCE | 0.74626755 |
| 76 | MYLK | 0.74597999 |
| 77 | TAOK3 | 0.74372028 |
| 78 | STK3 | 0.73109634 |
| 79 | CDK15 | 0.72668246 |
| 80 | PRKCI | 0.72230720 |
| 81 | MUSK | 0.72186257 |
| 82 | WNK3 | 0.71618556 |
| 83 | PKN1 | 0.70967017 |
| 84 | MAP2K6 | 0.70870729 |
| 85 | ADRBK2 | 0.69715876 |
| 86 | RPS6KA2 | 0.67730406 |
| 87 | SGK223 | 0.66679082 |
| 88 | SGK494 | 0.66679082 |
| 89 | CSNK1A1 | 0.66019616 |
| 90 | NEK2 | 0.65288324 |
| 91 | CSNK1E | 0.65251662 |
| 92 | LMTK2 | 0.63679994 |
| 93 | PRKCZ | 0.61559435 |
| 94 | STK11 | 0.61468842 |
| 95 | RIPK4 | 0.61231627 |
| 96 | TSSK6 | 0.61020438 |
| 97 | ROCK2 | 0.60968023 |
| 98 | TNIK | 0.59370994 |
| 99 | CDK11A | 0.59045665 |
| 100 | MAP4K2 | 0.58813458 |
| 101 | ADRBK1 | 0.58278566 |
| 102 | RET | 0.57953500 |
| 103 | MAP3K2 | 0.57794049 |
| 104 | EEF2K | 0.57535719 |
| 105 | CSNK1A1L | 0.56825025 |
| 106 | STK24 | 0.56538553 |
| 107 | NEK1 | 0.56414010 |
| 108 | PIK3CA | 0.56056865 |
| 109 | BMX | 0.55779328 |
| 110 | PRKAA1 | 0.54807760 |
| 111 | BCKDK | 0.54599914 |
| 112 | PTK6 | 0.52651122 |
| 113 | CCNB1 | 0.52157753 |
| 114 | PRKG1 | 0.51620424 |
| 115 | FER | 0.51606657 |
| 116 | MAPKAPK3 | 0.51514625 |
| 117 | PTK2B | 0.51321986 |
| 118 | CAMK4 | 0.51130479 |
| 119 | CAMK2G | 0.50028187 |
| 120 | OXSR1 | 0.49508469 |
| 121 | SGK2 | 0.49212295 |
| 122 | PRKCQ | 0.48951147 |
| 123 | WEE1 | 0.48572492 |
| 124 | CAMK1 | 0.48286674 |
| 125 | CSNK1G3 | 0.47833461 |
| 126 | RPS6KA3 | 0.47299601 |
| 127 | BMPR1B | 0.47180466 |
| 128 | CAMK1G | 0.46187015 |
| 129 | BMPR2 | 0.45459897 |
| 130 | MAP3K7 | 0.45246526 |
| 131 | CAMKK2 | 0.44459298 |
| 132 | CDK8 | 0.44398677 |
| 133 | PRKCA | 0.43775297 |
| 134 | PRKACA | 0.43044102 |
| 135 | MAP2K1 | 0.41943132 |
| 136 | ROCK1 | 0.41338747 |
| 137 | DAPK3 | 0.41289325 |
| 138 | SGK1 | 0.41008091 |
| 139 | ERBB4 | 0.40908506 |
| 140 | PRKAA2 | 0.40899623 |
| 141 | INSRR | 0.40523236 |
| 142 | PRKG2 | 0.39213887 |
| 143 | PRKDC | 0.39054153 |
| 144 | FYN | 0.38725003 |
| 145 | CSNK2A2 | 0.38522631 |
| 146 | PRKCH | 0.37986528 |
| 147 | MAPK9 | 0.36170929 |
| 148 | PRKCB | 0.36163750 |
| 149 | PRKACB | 0.35610562 |
| 150 | PDK2 | 0.35572138 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.76411946 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.16247550 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.12449297 |
| 4 | Sulfur relay system_Homo sapiens_hsa04122 | 3.05373731 |
| 5 | Parkinsons disease_Homo sapiens_hsa05012 | 2.68749729 |
| 6 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.57307231 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.49398342 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 2.44255322 |
| 9 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.42914726 |
| 10 | Alzheimers disease_Homo sapiens_hsa05010 | 2.30486080 |
| 11 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.23533198 |
| 12 | Olfactory transduction_Homo sapiens_hsa04740 | 2.19854759 |
| 13 | Circadian entrainment_Homo sapiens_hsa04713 | 2.15619299 |
| 14 | Morphine addiction_Homo sapiens_hsa05032 | 2.11179228 |
| 15 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.10686458 |
| 16 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.06112124 |
| 17 | Long-term potentiation_Homo sapiens_hsa04720 | 1.96127950 |
| 18 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.92149765 |
| 19 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.86420420 |
| 20 | Huntingtons disease_Homo sapiens_hsa05016 | 1.83885903 |
| 21 | Taste transduction_Homo sapiens_hsa04742 | 1.80507332 |
| 22 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.73882038 |
| 23 | Long-term depression_Homo sapiens_hsa04730 | 1.73416108 |
| 24 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.69454183 |
| 25 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.68677469 |
| 26 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.68153695 |
| 27 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.67369839 |
| 28 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.65802451 |
| 29 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.65702942 |
| 30 | Insulin secretion_Homo sapiens_hsa04911 | 1.63985949 |
| 31 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.63902339 |
| 32 | Salivary secretion_Homo sapiens_hsa04970 | 1.63025733 |
| 33 | Renin secretion_Homo sapiens_hsa04924 | 1.59960408 |
| 34 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.59179635 |
| 35 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.50791969 |
| 36 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.50569738 |
| 37 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.48910649 |
| 38 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.41874271 |
| 39 | Axon guidance_Homo sapiens_hsa04360 | 1.41312939 |
| 40 | Gap junction_Homo sapiens_hsa04540 | 1.39738925 |
| 41 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.36205210 |
| 42 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.34356803 |
| 43 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.33260618 |
| 44 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.32205667 |
| 45 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.31512303 |
| 46 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.29653855 |
| 47 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.25585476 |
| 48 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.21163642 |
| 49 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.20215782 |
| 50 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.17249923 |
| 51 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.16423966 |
| 52 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.15976758 |
| 53 | Cocaine addiction_Homo sapiens_hsa05030 | 1.13489426 |
| 54 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.11242064 |
| 55 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.07354975 |
| 56 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.05950550 |
| 57 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.05651172 |
| 58 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.04034356 |
| 59 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.02644586 |
| 60 | Ribosome_Homo sapiens_hsa03010 | 1.01923668 |
| 61 | ABC transporters_Homo sapiens_hsa02010 | 0.99357836 |
| 62 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.98315149 |
| 63 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.97608851 |
| 64 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.96777940 |
| 65 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.94927171 |
| 66 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.94554861 |
| 67 | Histidine metabolism_Homo sapiens_hsa00340 | 0.93704662 |
| 68 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.93503721 |
| 69 | Melanogenesis_Homo sapiens_hsa04916 | 0.93189313 |
| 70 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.92211500 |
| 71 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.88861884 |
| 72 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.88453127 |
| 73 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.86689416 |
| 74 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.86192878 |
| 75 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.85026981 |
| 76 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.84924267 |
| 77 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.84734657 |
| 78 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.84127249 |
| 79 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.80478890 |
| 80 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.80323932 |
| 81 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.79567875 |
| 82 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.78944968 |
| 83 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.78924061 |
| 84 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.78781670 |
| 85 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.78740549 |
| 86 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.77971951 |
| 87 | Peroxisome_Homo sapiens_hsa04146 | 0.77473111 |
| 88 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.77257936 |
| 89 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.77244497 |
| 90 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.76322014 |
| 91 | Phototransduction_Homo sapiens_hsa04744 | 0.74485505 |
| 92 | Retinol metabolism_Homo sapiens_hsa00830 | 0.74073241 |
| 93 | Mineral absorption_Homo sapiens_hsa04978 | 0.73837095 |
| 94 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.73668523 |
| 95 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.73498242 |
| 96 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.72324944 |
| 97 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.69729435 |
| 98 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.69703892 |
| 99 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.69380912 |
| 100 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.66328741 |
| 101 | Glioma_Homo sapiens_hsa05214 | 0.65977336 |
| 102 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.64450045 |
| 103 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.62878901 |
| 104 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.62746922 |
| 105 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.61581870 |
| 106 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.61522050 |
| 107 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.60269683 |
| 108 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.59637655 |
| 109 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.57565883 |
| 110 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.57533693 |
| 111 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.57282340 |
| 112 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.55636386 |
| 113 | Alcoholism_Homo sapiens_hsa05034 | 0.55507636 |
| 114 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.55396332 |
| 115 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.53419754 |
| 116 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.53325099 |
| 117 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.51527822 |
| 118 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.51241535 |
| 119 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.49965176 |
| 120 | Metabolic pathways_Homo sapiens_hsa01100 | 0.49524762 |
| 121 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.48834345 |
| 122 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.47560235 |
| 123 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.47399751 |
| 124 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.46241900 |
| 125 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.45643621 |
| 126 | Prion diseases_Homo sapiens_hsa05020 | 0.43883433 |
| 127 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.43322401 |
| 128 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.42865563 |
| 129 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.42226562 |
| 130 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.41428283 |
| 131 | Phagosome_Homo sapiens_hsa04145 | 0.40582951 |
| 132 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.38977448 |
| 133 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.38319211 |
| 134 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.37124313 |
| 135 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.37102872 |
| 136 | Colorectal cancer_Homo sapiens_hsa05210 | 0.35630643 |
| 137 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.35564041 |
| 138 | Endometrial cancer_Homo sapiens_hsa05213 | 0.35488690 |
| 139 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.34816981 |
| 140 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.32480196 |
| 141 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.32275818 |
| 142 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.30237495 |
| 143 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.29087536 |
| 144 | Bile secretion_Homo sapiens_hsa04976 | 0.26802301 |
| 145 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.24059716 |
| 146 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.23328969 |
| 147 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.22597549 |

